675602-63-8 Usage
Uses
Used in Pharmaceutical Industry:
2-(3'-PYRIDYL)PHENYLACETIC ACID is used as a precursor in the synthesis of pharmaceuticals for its aromatic structure and functional groups. Its anti-inflammatory and analgesic properties make it a potential candidate for the development of drugs targeting pain relief and inflammation management.
Used in Agrochemical Industry:
2-(3'-PYRIDYL)PHENYLACETIC ACID is utilized as a starting material in the production of agrochemicals, such as pesticides and herbicides, due to its chemical properties and reactivity. Its potential applications in this industry contribute to the development of effective and environmentally friendly solutions for crop protection.
Used in Antioxidant Applications:
2-(3'-PYRIDYL)PHENYLACETIC ACID is employed as an antioxidant, protecting cells and tissues from oxidative damage caused by free radicals. Its antioxidant properties can be harnessed in various industries, including pharmaceuticals, cosmetics, and food preservation, to enhance the shelf life and quality of products.
Used in Antimicrobial Applications:
2-(3'-PYRIDYL)PHENYLACETIC ACID is used as an antimicrobial agent, exhibiting activity against various microorganisms, including bacteria and fungi. Its potential applications in this area can be found in the development of antimicrobial products for healthcare, food safety, and sanitation purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 675602-63-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,5,6,0 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 675602-63:
(8*6)+(7*7)+(6*5)+(5*6)+(4*0)+(3*2)+(2*6)+(1*3)=178
178 % 10 = 8
So 675602-63-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H11NO2/c15-13(16)8-10-4-1-2-6-12(10)11-5-3-7-14-9-11/h1-7,9H,8H2,(H,15,16)
675602-63-8Relevant academic research and scientific papers
NOVEL SPECIFIC CASPASE-10 INHIBITORS
-
Page/Page column 28, (2008/06/13)
The invention relates to compounds of the general formula (I), and to their use as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
